Evotec’s in vitro transcription/translation (IVTT) platform provides fast, scalable cell-free protein expression to accelerate drug discovery and functional studies. The platform enables high-throughput screening of thousands of proteins, including biologics and enzymes, and supports milligram-scale production for downstream applications. Integrated with purification, quality control, and activity assays, Evotec’s IVTT services deliver rapid, reproducible expression of difficult-to-produce proteins, offering flexible solutions for research, structural biology and therapeutic development.

Diagram showing the central dogma of molecular biology: DNA transcribed into mRNA, which is translated into a protein sequence.

DNA to protein synthesis through transcription and translation

Evotec Expertise

Evotec’s in vitro transcription/translation expertise combines high-throughput cell-free expression with integrated purification and analysis, enabling rapid, scalable production of functional proteins.

  • Validated IVTT components offered as kits, single proteins, or reactions
  • High-throughput screening for thousands of proteins, biologics and enzymes
  • Integrated purification for small-scale protein recovery
  • Assay and activity integration for comprehensive functional data
  • Scalability to milligram production for downstream research and development

Featured In Vitro Transcription/Translation Services

Frequently Asked Questions

Q: What is IVTT expression?

  • In vitro transcription/translation (IVTT) is a cell-free protein synthesis method where DNA or mRNA is translated into proteins using ribosomes, amino acids, and tRNAs outside living cells.

Q: What are the advantages of IVTT expression?

  • Speed & efficiency – proteins produced within hours, faster than in vivo expression
  • Versatility – supports difficult-to-express proteins and interaction studies
  • Open system – easy optimization and addition of folding enhancers
  • High-throughput screening – parallel testing of multiple constructs
  • Accessibility – minimal specialized equipment required
  • Labeling options – incorporation of isotopes or unnatural amino acids

Q: What are the limitations of IVTT expression?

  • Limited post-translational modifications compared to living cells
  • Lower protein yields in some systems versus in vivo expression
  • No endogenous membranes, limiting certain protein types

Q: What are common applications of IVTT expression?

  • Studying protein–protein and protein–nucleic acid interactions
  • Rapid protein production for functional or mutant analysis
  • Folding and stability studies for complex proteins
  • Therapeutic development, supporting drug discovery and biologics research
James Errey

Dr. James Errey

VP, Head of Global Protein Production

vCard
Logo Evotec white
Evotec has the right technologies & disease understanding to meet our partners' evolving needs: a comprehensive disease knowledge at the molecular level, cutting-edge technologies & platforms to translate this expertise into effective precision medicines.